BioNTech SE (BNTX) EPS (Basic) (2018 - 2026)
BioNTech SE (BNTX) posted EPS (Basic) of -$0.72 for Q4 2025, down 289.96% sequentially from $0.38 in Q3 2025, and down 147.33% YoY from $1.52 in Q4 2024.
Powered by 
Analysis
BioNTech SE (BNTX) EPS (Basic) (2018 - 2026) Analysis & Trends
BioNTech SE has reported EPS (Basic) for 8 years, with the latest figure at -$0.72 in Q4 2025.
- Quarterly EPS (Basic) fell 147.33% year-over-year to -$0.72 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$4.37 (down 40.75% YoY) and the FY2025 annual result came in at -$5.31, down 79.58% from the prior year.
- EPS (Basic) slipped to -$0.72 in Q4 2025 per BNTX's latest filing, from $0.38 in the prior quarter.
- Over five years, EPS (Basic) peaked at $30.67 in Q3 2021 and troughed at -$3.6 in Q2 2024.
- A 5-year average of $6.98 and a median of $1.42 in 2024 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2025: EPS (Basic) soared 1359095601993.31% in 2021, then tumbled 147.33% in 2025.
- Over 5 years, EPS (Basic) stood at $0.0 in 2021, then soared by 114873606.68% to $17.05 in 2022, then sank by 77.22% to $3.88 in 2023, then tumbled by 60.76% to $1.52 in 2024, then sank by 147.33% to -$0.72 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.72, $0.38, and -$1.97 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | -3.06 |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | 0.18 |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | -0.06 |
| 10 | BioNTech SE | 25.10 Bn | 11.45 Bn | 10.00 Mn | -4.31 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -4.31 |
| Mar 31, 2026 | -2.40 |
| Dec 31, 2025 | -0.72 |
| Sep 30, 2025 | 0.38 |
| Jun 30, 2025 | -1.97 |
| Mar 31, 2025 | -1.88 |
| Dec 31, 2024 | 1.52 |
| Sep 30, 2024 | 0.54 |
| Jun 30, 2024 | -0.48 |
| Mar 31, 2024 | 0.10 |
| Dec 31, 2023 | 3.88 |
| Sep 30, 2023 | -0.04 |
| Jun 30, 2023 | 0.04 |
| Mar 31, 2023 | 0.00 |
| Dec 31, 2022 | 17.05 |
| Sep 30, 2022 | 0.05 |
| Jun 30, 2022 | 12.97 |
| Mar 31, 2022 | 29.15 |
| Dec 31, 2021 | 14.84 |
| Sep 30, 2021 | 30.67 |